Alex Zhebrak

Alex Zhebrak is a technology leader specializing in machine learning and drug discovery, currently serving as VP of Engineering at Relation Therapeutics in London, England.1 His career highlights include:

1. VP Engineering at Relation Therapeutics (current position)1
2. VP Engineering, Drug Discovery at Lifebit (May 2023 - September 2023)1
3. Chief Technology Officer at Insilico Medicine, Inc. (May 2017 - March 2021)1

During his tenure at Insilico Medicine, Zhebrak managed the R&D department's growth from 4 to 40 people, oversaw collaborations with top pharmaceutical companies, and led research on machine learning applications in drug discovery.1 He has also been involved in academia, co-authoring a Python programming Specialization on Coursera with 80,000 enrolled students and teaching at Moscow State Technical University.1

Zhebrak has demonstrated a commitment to social causes, volunteering to assist Ukrainian refugees at Berlin Central Station in April 2022.2 He has also expressed support for Ukraine during the ongoing conflict.3 Recently, Zhebrak announced that Relation Therapeutics secured $35 million in financing led by DCVC and co-led by NVIDIA's venture arm.4